Immuno‑Oncology (I‑O) is a rapidly evolving field that focuses on the immune system in the fight against cancer. Today, surgery, radiation, and cytotoxic/targeted therapies are common treatment approaches in many advanced cancers. However, global mortality rates remain high for many patients with advanced tumors. The goal of Immuno-Oncology (I-O) research is to fulfill the unmet need for improving clinical outcomes in several advanced cancers by finding new ways to stop cancer from evading the immune system, thereby restoring the body's natural ability to recognize and eliminate cancer.
On October 6th, 2015 ShareVault presented a live web panel where the panelists discussed what was exciting in the immuno-oncology field. The discussion was so popular that we've decided to follow it up with a second web panel, "Even More of What's Hot in Immuno-Oncology Licensing"
December 10th, 2015 from 2 - 3:15 EDT / 11 - 12:15 PDT.